Recombinant adeno-associated virus (rAAV) transduction is limited in vivo, yet can be enhanced by hydroxyurea, ultravioletirradiation, or adenovirus coinfection, possibly via mechanisms involving stress in the host cell. Because chronic ethanol induces oxidative stress, it was hypothesized that chronic ethanol would increase rAAV transduction in vivo. To test this hypothesis, rAAV encoding ␤-galactosidase was given to Wistar rats that later received either ethanol diet or high-fat control diet via an enteral-feeding protocol for 3 weeks. Expression and activity of ␤-galactosidase in the liver were increased nearly 5-fold by ethanol. The increase in transgene expression was inhibited by antioxidant diphenylene iodonium (DPI), which is consistent with the hypothesis that ethanol causes an increase in rAAV transduction via oxidative stress. Ethanol increased DNA synthesis only slightly; however, it increased the nuclear transcription factor B (NFB) 4-fold, a phenomenon also sensitive to DPI. Moreover, a 6-fold increase in rAAV transgene expression was observed in an acute ischemia-reperfusion model of oxidative stress. Transgene expression was transiently increased 24 hours after ischemia-reperfusion 3 days and 3 weeks after rAAV infection. Further, adenoviral expression of superoxide dismutase or IB␣ superrepressor inhibited rAAV transgene expression caused by ischemia-reperfusion. Therefore, it is concluded that ethanol increases rAAV transgene expression via mechanisms dependent on oxidative stress, and NFB likely through enhancement of cytomegaloviral (CMV) promoter elements. Alcoholic liver disease is an attractive target for gene therapy because consumption of ethanol could theoretically increase expression of therapeutic genes (e.g., superoxide dismutase). Moreover, this study has important implications for rAAV gene therapy and potential enhancement and regulation of transgene expression in liver. (HEPATOLOGY 2000;32:1050-1059.) Adeno-associated virus (AAV)-mediated gene delivery is attractive because it can theoretically provide long-term, stable expression of a transgene. 1,2 Recombinant AAV (rAAV) is also a useful tool for liver-directed gene delivery because the virus can infect nondividing cells, integrate specifically into the host cell genome, and is relatively nonpathogenic compared with more commonly used adenoviral vectors. 1 Although rAAV provides many advantages over other vectors, its transduction efficiency in many tissues, including the liver, is limited either because of the requirement of synthesis of the second strand of DNA in the viral genome 3,4 or because of the lack of transgene expression caused by decreased promoter activity (i.e., inactivation of the cytomegalovirus [CMV] promoter). 5 Second-strand synthesis of the single-stranded AAV viral genome, which is required for the expression of the transgene, is hypothesized to be the limiting step in transduction; however, the cellular mechanisms for this process remain unclear. Various genotoxic agents, such as etoposide and hydroxyurea, as well as coinfection with helper viruses such as adenovirus or herpes virus, have been shown to increase rAAV transduction. 3, 4, 6 Moreover, many agents shown to increase rAAV transduction in vitro also cause mild cellular damage and induce many cellular stress responses such as activation of nuclear transcription factor B (NFB). 7-9 An alternative hypothesis is that rAAV transduction is regulated through cellular proliferation or transcription factors rather than through an increase in cellular DNA synthesis. In fact, recent evidence showed that rAAV transduction efficiency is influenced by several factors including cell type, the proliferative stage of the host cell, or condition of the infected cell or tissue. 10, 11 Ethanol, a known hepatotoxicant, causes oxidative injury and mild DNA damage. 12,13 Therefore, it was hypothesized that chronic enteral ethanol via an intragastric feeding protocol would increase rAAV transduction in vivo. The enteral ethanol-feeding model developed by Tsukamoto et al. 14 is an animal model characterized by the development of severe liver pathology, which is characteristic of the human disease. Alcohol-induced liver injury is a chronic condition of severe oxidative stress caused by hypoxia-reoxygenation and free radical production from activated Kupffer cells, the resident hepatic macrophages. 15, 16 Here, it is reported that chronic ethanol increases transgene expression by rAAV about 4-fold in the liver. Also, the increase in transduction is correlated with an increase in liver injury and activation of NFB. These studies suggest that increased rAAV transgene expression can be potentially maximized through modulation of critical host
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MATERIALS AND METHODS
Experimental Design. Male Wistar rats (ϳ250 -300 g) were used in all experiments, which included 4 treatment groups (high-fat control animals, high-fat control animals infected with rAAV.CMV.lacZ, ethanol-treated animals, and ethanol-treated animals infected with rAAV.CMV.lacZ). Animals received virus intravenously 24 hours before the delivery of enteral diet and were then given ethanol-containing diet or high-fat control diet by continual enteral feeding for 3 weeks. Portal blood was collected for serum transaminase measurements, animals were killed, and livers were harvested. Sections were either snap frozen and stored at Ϫ80°C or fixed in 10% neutralbuffered formalin and kept until further analysis.
Tsukamoto-French Enteral Ethanol Delivery. Animals. Male Wistar rats (250 -300 g) used in this study were housed in compliance with the American Association for Accreditation of Laboratory Animal Care and institutional guidelines. An intragastric cannula was implanted into each rat as described by Tsukamoto at al. 14 Briefly, cannulas were tunneled subcutaneously to the dorsal aspect of the neck and attached to infusion pumps by means of a spring-tether device and swivel, allowing complete mobility of the rats within metabolic cages. Animals were infused continuously with a high-fat liquid diet or a diet containing ethanol through the intragastric cannula for 3 weeks. For ischemia-reperfusion experiments, animals were anesthetized by using sodium pentobarbital (75 mg/kg, intraperitoneally [ip]). Livers were made ischemic for 1 hour by using portal vein clamping in vivo, as described by Colletti et al. 17 Diets. The basic liquid diet was prepared according to Thompson and Reitz 18 and was supplemented with lipotropes as described previously. 19 The diet contained corn oil as fat (37% of total calories), protein (23%), carbohydrate (5%), minerals and vitamins, plus ethanol (35%). For the control high-fat diet, ethanol was replaced with dextrin-maltose. Animals were allowed to recover for 1 week after surgery before enteral ethanol was initiated. Ethanol levels in the diet were gradually increased to 10 to 12 g/kg/d during the first week of ethanol administration and maintained near 12 g/kg/d for the remainder of the experiment.
Clinical Chemistry. Urine alcohol concentration (UAC) was determined daily by standard enzymatic alcohol analysis. UAC is reported as the average of daily UAC from samples collected during the ethanol treatment. Serum aspartate and alanine transaminase levels were determined by standard enzymatic assays (Sigma, St. Louis, MO) by using portal blood collected at death.
rAAV Preparation. rAAV.CMV.lacZ and rAAV.CMV.egfp contained the reporter transgenes for bacterial ␤-galactosidase and enhanced A. victorialis green fluorescent protein (EGFP) under control of the CMV promoter and were prepared in human HEK 293 cells as described previously. 20 For some experiments, the CMV promoter sequence in the rAAV.CMV.egfp vector was replaced with the transthyritin (TTR) gene promoter elements 21 by using standard cloning procedures, and the rAAV.TTR.egfp vector was prepared as described earlier. The Ad vector Ad.CMV.EGFP contains the transgene for the EGFP reporter. The Ad.SOD1 (a kind gift from Dr. John Engelhardt, University of Iowa) and Ad.IB␣ adenoviral vectors contain the transgenes for human Cu/Zn-superoxide dismutase and the NFB superrepressor IB␣, respectively. The adenoviral vectors were prepared by the University of North Carolina Viral Vector Core as described previously. 22, 23 Detection of Transgene. ␤-galactosidase histochemistry. Formalin-fixed sections (8 m) were stained for ␤-galactosidase. Briefly, fixed sections were incubated in phosphate-buffered saline containing 5 mmol/L potassium ferricyanide, 5 mmol/L potassium ferrocyanide, 2 mmol/L magnesium chloride, 0.02% Nonidet P-40 (wt/vol), 0.01% sodium deoxycholate (wt/vol), and 1 mg/mL 5-bromo-4-chloro-3-indolyl-␤-D-galactopyranoside (X-gal) (Sigma) for 24 to 48 hours at 37°C. Sections were then lightly counterstained with eosin. [ONPG] ) was added to the extract and incubated for 30 minutes at room temperature. To stop the reaction, 500 L of a 2.8% sodium carbonate solution was added. The activity ␤-galactosidase was quantified by using the cleavage of ONPG to nitrophenyl that was measured spectrophotometrically at 420 nm and normalized to total protein determined with the Bio-Rad protein assay (Bio-Rad Laboratories, Hercules, CA).
Western blot. Whole liver tissue was homogenized in buffer A (40 mmol/L Tris, 140 mmol/L NaCl, 1 mmol/L DTT, 10 mg/mL PMSF, 1 mg/mL aprotinin, and 1 mg/mL leupeptin). The homogenate was centrifuged at 900g, the supernatant was collected. Protein (10 g) was diluted in buffer A to a final volume of 15 L. A 15-L aliquot of 2ϫ Laemelli buffer was added to the sample, which was heated at 95°C for 5 minutes before loading on the gel. Samples were resolved by electrophoresis by using 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). Protein was transferred onto nitrocellulose by using a semidry transfer method. The membranes were incubated in a 1:2,000 dilution of mouse monoclonal anti-␤-galactosidase antibody (Boehringer Mannheim, Mannheim, Germany) or a 1:1,000 dilution of rabbit polyclonal anti-green fluorescent protein (GFP) antibody (Clontech, Palo Alto, CA) for 2 hours at room temperature. Then membranes were transferred to a solution containing a 1:5,000 dilution of secondary anti-mouse or anti-rabbit immunoglobulin (Ig)G-horseradish peroxidase (HRP)-conjugated antibody (Amersham Life Sciences, Buckinghamshire, England) and incubated for 1 hour. The membranes were washed 3 times for 10 minutes in fresh triethanolamine-buffered saline/0.05% Tween-20 between each step. Finally, the membranes were washed 3 times for 15 minutes and added to ECL Western Detection Reagent (Amersham Life Sciences).
Immunohistochemical staining for GFP. Formalin-fixed, paraffin-embedded sections (8 m) were mounted on glass slides. Sections were deparaffinized and rehydrated and then stained with mouse anti-GFP primary antibody (Clontech) for 30 minutes. The immunostaining was visualized by using the DAKO (Carpinteria, CA) immunostaining kit. Slides were counterstained with hematoxylin. Primary antibody dilutions were 1:100 in phosphate-buffered saline containing 1% Tween-20.
Electromobility Shift Assay (EMSA) for NFB. Nuclear extracts were prepared from whole liver homogenate as previously described by Dignam et al. 24 by lysing cells in Nonidet P-40 (0.25%) in 10 mmol/L HEPES, pH 7.6, containing 10 mmol/L KCl, 2 mmol/L MgCl 2 , 1 mmol/L DTT, 0.1 mmol/L EDTA, and small protease inhibitors. Homogenate was centrifuged at 13,000g for 10 minutes and the nuclear pellet was resuspended in 50 mL of 50 mmol/L HEPES, pH 7.6, containing 50 mmol/L KCl, 300 mmol/L NaCl, 1 mmol/L DTT, 0.1 mmol/L EDTA, small protease inhibitors, and 10% glycerol. After gentle mixing for 15 minutes, the mixture was centrifuged at 13,000g for 7 minutes. The supernatant was collected and stored at Ϫ80°C.
Electromobility shift assays of nuclear extracts (40 g) were performed with radiolabeled oligonucleotide probes specific for NFB. 25, 26 The probe was labeled at the 5Ј-end by using T4 kinase and [␥-32 P] adenosine triphosphate (3,000 Ci/mmol). Excess adenosine triphosphate was separated from the labeled probe through sequential ethanol precipitation. Protein-DNA complexes were separated through native 5% PAGE and visualized by autoradiography. The DNA-protein complex was supershifted by using antibodies specific for the p50 and p65 subunits (a kind gift from N. Rice, National Cancer Institute) of the active NFB complex. The densi-tometric quantification of NFB binding was performed by using Scion Image 1.62 software.
RESULTS

Routine Parameters.
Ethanol was given in a high-fat diet at 12 g/kg/d via a gastric feeding tube by using an enteral feeding model. This ethanol-feeding model is characterized by severe steatosis, mild necrosis, and lymphocytic infiltration and represents the human disease more closely than other rodent models. Here, ethanol-treated animals exhibited an increase in UAC that cycled between 60 and 250 mg/dL and maintained an average UAC near 180 mg/dL ( Table 1 ). The cyclic pattern in UAC is typical, but reasons for it are not understood. Importantly, the delivery of rAAV.CMV.lacZ had no effect on the concentration of alcohol or the cyclic pattern in the urine in this model.
Serum aspartate transaminase and alanine transaminase levels were not increased in rats infected with recombinant AAV and values were not different from enzyme levels of normal animals (data not shown), indicating that rAAV by itself does not contribute to liver injury. As expected, however, transaminases were increased significantly about 4-fold in ethanol-treated animals compared with high-fat controls (Table 1) .
In animals that received control high-fat diet, minimal pathologic changes were observed regardless of whether or not virus was given (Fig. 1A and 1B) . However, histologic analysis of ethanol-treated animals showed marked increases in panlobular fat accumulation, lymphocyte infiltration, and necrosis as expected ( Fig. 1C and 1D) .
Chronic Ethanol Increases rAAV Transgene Expression. To test the hypothesis that ethanol would increase rAAV transduction in the liver, Wistar rats receiving rAAV encoding the bacterial reporter gene ␤-galactosidase were given ethanol via an intragastric enteral feeding protocol for 3 weeks. rAAV (1 ϫ 10 10 particles) was given intravenously to animals 24 hours before initiation of ethanol diet. After 3 weeks of ethanol delivery, the expression of ␤-galactosidase was measured by 5-bromo-4-chloro-3-indolyl-␤-D-galactoside (X-gal) staining (Fig. 2) and quantified by Western blotting by using a polyclonal antibody specific for ␤-galactosidase (Fig. 3A) . X-gal staining showed ␤-galactosidase expression in periportal regions of livers of animals infected with rAAV.CMV.lacZ. Moreover, ethanol caused a significant increase in ␤-galactosidase expression compared with expression observed in livers of animals fed a high-fat control diet. ␤-Galactosidase expression, measured by Western blot analysis, was increased nearly 4-fold by chronic ethanol compared with rats that received high-fat control diet (Fig. 3B) . ␤-Galactosidase expression was not observed in saline-injected control animals that received either high-fat control diet or diet containing ethanol, as expected. The activity of ␤-galactosidase was measured by the enzymatic cleavage of the substrate ONPG (Fig. 3C) . In rats given rAAV.CMV.lacZ and treated with ethanol for 3 weeks, ␤-galactosidase activity was increased nearly 4-fold over control animals treated with rAAV and high-fat diet alone. The increase in ␤-galactosidase activity is consistent with the increase in transgene expression detected by Western blotting, indicating that the increase in transgene activity is a direct result of rAAV transduction and expression of a functional transgene. Thus, it is concluded that rAAV transgene expression is increased dramatically by chronic ethanol. Urine was collected from animals in all treatment groups and average UAC was determined as described in the Materials and Methods section. Serum aspartate transaminase (AST) and alanine transaminase (ALT) levels were measured by standard enzymatic procedures from blood collected from the inferior vena cava before necropsy. Pathology was scored on the basis of steatosis (0-4), inflammation (0-2), and necrosis (0-2). Data are expressed as mean Ϯ SD and are representative of 4 individual experiments.
* P Ͻ .05 compared with high-fat controls, 2-way ANOVA with Tukey's post-hoc analysis.
caused by ethanol given via the Tsukamoto-French protocol, suggesting that alcohol-induced liver injury is dependent on oxidative stress. 27 Animals were given rAAV.CMV.lacZ (1 ϫ 10 10 particles), then ethanol, and treated daily with DPI (1 mg/kg, subcutaneously) or 5% glucose vehicle for 3 weeks, and ␤-galactosidase transgene expression was measured biochemically as described earlier. In this study, DPI treatment nearly completely prevented ethanol-induced pathologic changes as well as increases in serum transaminases, confirming earlier work (data not shown). Importantly, ethanol caused a 6-fold increase in transgene expression in animals that received vehicle (Fig. 4) . However, treatment with DPI prevented the increase in ␤-galactosidase expression caused by ethanol completely. Moreover, when histochemical analysis of transgene expression was performed by using X-gal, the increase in ␤-galactosidase staining caused by ethanol was attenuated by DPI treatment (data not shown). Importantly, because DPI is a potent antioxidant, these data support the hypothesis that ethanol-induced transgene expression is mediated via oxidative stress.
Role of NFB in Chronic Ethanol-Induced rAAV Transgene Expression. Ethanol is a potent inducer of oxidative stress and it is well known that oxidants activate specific cellular stress responses such as NFB. 28 Because rAAV transgene expression is increased by chronic ethanol and is sensitive to antioxidants, the question of whether NFB activation is involved in ethanol-induced rAAV transduction was evaluated. NFB was measured in nuclear extracts by electromobility shift as- says. Active NFB-oligonucleotide complex was supershifted by using antibodies against the p50 and p65 subunits of the NFB heterodimer, but not with nonspecific IgG antibody, and was competitively inhibited by using excess unlabeled oligonucleotide (Fig. 5A) . These data confirm the specificity of NFB binding in these experiments and indicate that the NFB complex consists of the p50 and p65 subunits. There was no activation of NFB after 3 weeks of high-fat control diet in either saline-or rAAV.CMV.lacZ-treated animals. However, in animals treated with ethanol, NFB binding was increased significantly nearly 4-fold, which is consistent with other reports (Fig. 5C ). 29 Moreover, treatment with the antioxidant DPI blunted the activation of NFB (Fig. 5C) . 27 These data suggest that NFB may be responsible for transgene expression. Because rAAV transgene expression is driven by the CMV promoter, and the CMV promoter can be regulated by 
FIG. 4. DPI inhibits ethanol-induced rAAV transgene expression. Male
Wistar rats were injected with rAAV.CMV.lacZ (10 10 particles) before receiving an intragastric diet containing dextrin-maltose (Con) or ethanol (EtOH) via the Tsukamoto-French protocol for 3 weeks. Animals were also treated daily subcutaneously with either 5% glucose vehicle control (Vehicle) or with 1 mg/kg DPI. Liver extracts were prepared and ␤-galactosidase activity was measured by the enzymatic conversion of the colorimetric substrate ONPG to nitrophenyl. Data are expressed as mean Ϯ SEM and are representative of 4 individual experiments. ( a P Ͻ .05, compared with vehicle-treated controls; b P Ͻ .05, compared with vehicle-treated animals that received ethanol, 2-way ANOVA with Tukey's post-hoc analysis.) NFB and several other stress activated factors, 5, 30 it is reasonable to hypothesize that ethanol increases transgene expression through activation of NFB (see later).
Acute Oxidative Stress Induces rAAV Transgene Expression.
Based on the data mentioned earlier, it is hypothesized that oxidative stress activates NFB, which drives transgene expression. To test this hypothesis, rAAV transgene expression and the role of NFB was evaluated by using a warm ischemiareperfusion model of oxidative stress. This model is used because it is an acute in vivo model in which oxidative stress and activation of NFB can be induced rapidly (ϳ1 hour) and performed repeatedly, procedures that would be impractical in the enteral ethanol model. Ischemia reperfusion caused a 5-fold increase in ␤-galactosidase activity in the livers of animals given rAAV.CMV.lacZ (10 10 particles) compared with sham-operated controls that received recombinant virus (Fig.  6A) . Moreover, transgene expression induced by ischemia reperfusion was also sensitive to antioxidant treatment. These data show that oxidative stress induced by ischemia reperfusion increases rAAV transgene expression such as ethanol treatment.
Oxidative Stress-Induced rAAV Transgene Expression Is Transient. In animals that received rAAV.CMV.lacZ and underwent ischemia-reperfusion 3 days after infection, there was a 4-fold increase in ␤-galactosidase measured 24 hours after reperfusion, as in the experiments detailed earlier (Fig. 6B) . However, ␤-galactosidase activity returned to control levels 3 weeks after ischemia reperfusion. Ischemia reperfusion 3 weeks after infection also transiently increased ␤-galactosidase activity by nearly 5-fold, and transgene expression, which also returned to control values in 3 weeks.
Increases in rAAV Transgene Expression by Oxidative Stress Are
Inhibited by Superoxide Dismutase and IB␣. A definitive role of NFB in rAAV transduction has been lacking despite many studies. 31 Selective inhibitors of NFB are limited and many of the in vitro models used to investigate NFB involve immortalized cell lines that have alterations in many cellular regulatory mechanisms including NFB. Thus, the role of NFB in rAAV transduction was evaluated here in vivo. Animals were infected with rAAV.CMV.lacZ (10 10 particles) as well as with recombinant adenovirus containing the transgene for either enhanced green fluorescent protein (Ad.EGFP), human superoxide dismutase (Ad.SOD1), or IB␣ superrepressor (Ad.IB). Three days after infections, animals underwent ischemia reperfusion, and NFB activation and ␤-galactosidase activity were evaluated 2 and 24 hours later, respectively ( Fig. 7A and 7B) . NFB was activated after ischemia reperfusion in both saline and Ad.EGFP-treated animals, as expected (Fig. 7A) . However, NFB was not activated after ischemia reperfusion in animals treated with either Ad.SOD1 or Ad.IB␣. Animals given rAAV.CMV.lacZ coinfected with Ad.EGFP exhibited a 6-fold increase in ␤-galactosidase activity 24 hours after ischemia reperfusion compared with shamoperated animals. In contrast, ␤-galactosidase activity was not increased in livers from animals coinfected with Ad.SOD1 or Ad.IkB. These data provide strong evidence that oxidative stress increases rAAV transgene expression in vivo. Moreover, these data are consistent with the hypothesis that NFB activation is required for oxidative stress-induced increases in rAAV transgene expression. The Role of the CMV Promoter in Oxidative Stress-Induced Increase in rAAV Transgene Expression. The CMV promoter contains several putative NFB-binding regions. 5, 32 Thus, to test the hypothesis that NFB-dependent enhancement of rAAV transgene expression caused by oxidative stress was caused by activation of the CMV promoter, studies were performed by using rAAV containing the transgene for EGFP under the control of the promoter region for the TTR gene (rAAV. TTR.egfp). The TTR promoter provides liver-specific gene expression and is devoid of NFB-responsive elements. 21 Animals were infected with rAAV.CMV.egfp or rAAV.TTR.egfp (2 ϫ 10 9 particles/animal) for 3 days and then underwent ischemia reperfusion or sham operation. Livers were harvested 24 hours later and evaluated for GFP transgene expression by Western blot and immunohistochemical staining (data not shown). In animals infected with rAAV.CMV.egfp, ischemia reperfusion increased GFP expression nearly 4-fold compared with sham-operated control animals, as expected. However, in rAAV.TTR.egfp-infected animals, transgene expression was not significantly increased after ischemia reperfusion. These data are shown with both Western analysis and immunohistochemistry. Moreover, these data indeed support the hypothesis that enhancement of rAAV transgene expression mediated most likely through activation of the CMV promoter.
DISCUSSION
Chronic Ethanol Induces rAAV Transgene Expression Through
Oxidative Stress. The delivery of genes to the liver via AAV provides many advantages: (1) it has a broad host cell range, (2) it is not immunogenic or pathogenic, (3) it provides longterm expression, and (4) it has the ability to transduce nondividing cells. 1 Although these advantages make AAV an attractive gene delivery system for the liver, rAAV transduction in the liver is inefficient, transducing only approximately 3% to 5 % of the cells. 33 Many agents and methods used to increase rAAV transduction and transgene expression also cause oxidative stress in vivo. Indeed, it was recently shown that oxidative stress in vitro increased rAAV transduction in immortalized cell lines. 34 Ethanol, which causes oxidative stress in the liver, 15 also induces rAAV transgene expression in vivo (Figs. 2 and 4) . 16 Interestingly, the increase in rAAV transduction is increased because of ethanol in periportal regions of the liver. There may be 2 possible explanations for this finding. First, zonal distribution of rAAV transgene expression may be a reflection of the cells that are primarily infected, suggesting that periportal hepatocytes are more permissive to rAAV. Another possibility is that ethanol-induced oxidative stress is largely mediated by activated Kupffer cells and infiltrating neutrophils, which produce superoxide largely in periportal regions.
Although the mechanism for alcohol toxicity to the liver is still debated, the production of oxidants caused by ethanol clearly occurs. 35 The role of oxidant production in the development of liver injury is also debatable, but it is known that oxidants activate NFB 28, 36 and subsequently increase expression of TNF␣, a critical inflammatory cytokine involved in alcohol-induced liver injury. 37 In the Tsukamoto-French model, ethanol increases electron spin resonance-detectable radical production, providing direct evidence of oxidative stress. 15 Moreover, oxidative stress has recently been shown to induce rAAV transduction in cell culture. 31 Because treatment with the antioxidant DPI inhibited transgene expression caused by ethanol (Fig. 4) , it is concluded that ethanol increases rAAV transgene expression through oxidative stressdependent mechanisms.
Ethanol Enhancement of rAAV Transduction Is Not Likely Medi-
ated Through an Increase in DNA Synthesis. Ethanol in several models has been shown to cause mild DNA damage, possibly leading to the induction of repair mechanisms, such as nucleotide excision repair. 13 However, little evidence supports the hypothesis that ethanol increases DNA synthesis. In fact, it is reported that ethanol attenuates the proliferative effects of many agents. 38, 39 Because it has been reported that the synthesis of the second strand of viral DNA is the limiting step in the transduction of rAAV, 3 and that cellular enzymes such as PCNA may facilitate rAAV transduction, 8, 26 it seemed likely that ethanol increased rAAV transduction via mechanisms dependent on DNA synthesis. However, in this model, there is only a modest increase in cellular DNA synthesis that is most likely caused by viral infection and not caused by ethanol (data not shown). Moreover, the high rate of normal liver cell proliferation may be sufficient to support rAAV double-strand conversion. Evidence supporting this hypothesis is that rAAV genomes nearly completely become double stranded over a period of 3 to 4 weeks in liver cells in vivo. 40 Thus, the rAAV genome becomes double stranded in the absence of a transducing agent within the time frame used in these experiments, suggesting that second-strand conversion occurred in the absence of ethanol (see later).
In the acute warm ischemia-reperfusion model of oxidative stress, transgene expression was transiently increased over control levels in a fashion similar to ethanol (Fig. 6A) . The warm ischemia-reperfusion model was used here because it is practical and rapid. Hence, oxidative stress can be induced quickly compared with the chronic ethanol-feeding model. This model was used to address the hypothesis that oxidative stress does not influence transduction by increasing singlestrand conversion of the rAAV genome, but rather causes transient changes in transgene transcription. Indeed, transgene expression was transiently elevated 5-fold within 24 hours after reperfusion compared with sham-operated controls that received rAAV (Fig. 6B) ; however, it returned to control levels after 3 weeks. If ethanol caused an increase in cellular DNA synthesis leading to single-stranded conversion, transgene expression would be expected to remain elevated. Moreover, because expression of ␤-galactosidase is transiently induced by ischemia reperfusion, it is concluded that oxidative stress acts at the level of transcription, not secondstrand conversion. However, it has recently been shown that enhancement of second-strand synthesis may not necessarily contribute to sustained transgene expression and that mechanisms involved in transient expression may be different from those leading to persistent transgene expression from AAV vectors. 41 Oxidative Stress-Induced rAAV Transgene Expression Involves NFB. Chronic ethanol causes activation of NFB via the production of oxidants. 27 Here, it is reported that NFB activation is correlated with ethanol-induced transgene expression (Fig. 5) . Whether or not NFB activation is related to transgene expression is difficult to address experimentally because many inhibitors of NFB are either nonselective or have antioxidant properties, but the involvement of NFB is likely because it is activated by oxidants. 36 Although NFB has also been shown to influence several factors involved in the cell cycle, 42 it seems more likely that NFB activates transgene transcription. The role of NFB in rAAV transduction has been evaluated in several in vitro models, yet, its precise role remains unclear. Recently, it was shown in cell culture that expression of dominant-negative IB␣ blocked NFB activation, but had no effect on rAAV transduction (i.e., secondstrand DNA synthesis). 31 However, many studies have remarkably different outcomes in vitro compared with cell culture and in vivo because immortalized cells often have compensatory signaling mechanisms and altered regulation of the cell cycle. For example, by using an in vivo model of oxidative stress such as the ischemia-reperfusion model, the increase in transgene expression was inhibited by IB␣ repressor protein (Fig. 7) . Thus, it is concluded that NFB plays a critical role in rAAV transduction and transgene expression in vivo. It is also of interest that recombinant adenoviral infection did not significantly increase basal rAAV transduction because E4 ϩ adenovirus provides helper function for rAAV transduction. However, the dose of recombinant adenovirus in these studies is most likely too low to significantly enhance rAAV transduction in vivo.
NFB is also known to contribute to CMV promoter activity in several cell types most likely by binding to 3 NFB consensus binding sites within the CMV promoter region. 5, 32 The transient increase in transgene expression after ischemia reperfusion suggest that the observed increase may be caused by transcriptional regulation (Fig. 6) . Moreover, it was recently reported that rAAV transgene expression could be induced repeatedly by lipopolysaccharide administration in an arthritis model in the rat. 11 These data clearly suggest that disease state or oxidative stress (i.e., by lipopolysaccharide or ethanol) increases rAAV transgene expression likely through NFB or other stress response transcription factors. The inhibition of NFB in vivo by using both antioxidant superoxide dismutase and dominant-negative IB␣ supports the hypothesis that oxidative stress increases NFB, leading to rAAV transgene expression (Fig. 7) . Whether or not enhancement is completely caused by activation of the CMV promoter by NFB or some general feature of rAAV biology is not fully understood; however, recent data suggests that transgene enhancement caused by oxidative stress may be dependent on activation of stress-induced promoter elements (data not shown).
Therapeutic Implications. The concept that rAAV may become useful in targeting liver diseases becomes more attractive in light of data that suggests that oxidative stress in the liver may be sufficient to increase transgene expression. rAAV typically transduces approximately 3% to 5% of the liver 33 and provides low levels of transgene expression compared with other viral vectors. However, here, transgene expression from rAAV can be elevated to include nearly approximately 20% to 25% of the liver. As mentioned earlier, the use of ethanol or oxidative stress to increase rAAV transduction has important implications in developing techniques to increase transgene expression. Because oxidative stress has been reported to increase rAAV transduction, 34 and here it is shown that oxidative stress can improve rAAV transgene expression, these findings may represent a new tool to improve gene delivery to liver with rAAV. Additionally, inducers of oxidative stress such as acute ethanol, endotoxin, or brief periods of hypoxia caused by vessel clamping (e.g., as performed in routine abdominal surgery) may also be useful to increase the efficiency of rAAV. The finding that transgene up-regulation is dependent on transcriptional activation of the CMV promoter suggests that this promoter may be useful for disease-state regulation of the transgene, especially for diseases involving oxidative stress such as alcohol-induced liver injury.
Because alcohol-induced liver injury and cirrhosis is on a steady rise and therapies are lacking, a gene therapy approach is attractive. For example, rAAV-encoding antioxidant enzymes, such as superoxide dismutase and catalase, soluble TNF receptor, or dominant-negative TGF␤ receptor may be useful in preventing or treating alcoholic liver disease. Furthermore, because oxidative stress increases rAAV transgene expression, rAAV becomes even more attractive as a therapeutic tool for many conditions such as alcoholic liver disease, organ transplantation, or chemical toxicity where oxidative stress occurs. Moreover, oxidative stress induced by the disease state can, in fact, regulate the expression of therapeutic transgenes.
